Waters Corporation $WAT Stock Holdings Decreased by Investment House LLC

Posted by Brenda Bartman on Oct 23rd, 2026

Investment House LLC reduced its stake in shares of Waters Corporation (NYSE:WAT – Free Report) by 62.9% in the third quarter, HoldingsChannel reports. The firm owned 5,257 shares of the medical instruments supplier’s stock after selling 8,906 shares during the period. Investment House LLC’s holdings in Waters were worth $2,310,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Cardinal Capital Management boosted its holdings in shares of Waters by 4.2% in the 3rd quarter. Cardinal Capital Management now owns 4,422 shares of the medical instruments supplier’s stock valued at $1,943,000 after buying an additional 178 shares in the last quarter. Cantor Fitzgerald Investment Advisors L.P. purchased a new position in shares of Waters in the 3rd quarter worth approximately $13,678,000. Axxcess Wealth Management LLC grew its position in shares of Waters by 27.4% in the 3rd quarter. Axxcess Wealth Management LLC now owns 711 shares of the medical instruments supplier’s stock worth $312,000 after buying an additional 153 shares during the last quarter. Crossmark Global Holdings Inc. raised its stake in shares of Waters by 0.6% during the 3rd quarter. Crossmark Global Holdings Inc. now owns 9,542 shares of the medical instruments supplier’s stock worth $4,193,000 after acquiring an additional 55 shares in the last quarter. Finally, Sowell Financial Services LLC bought a new position in shares of Waters during the 3rd quarter worth approximately $207,000. Institutional investors own 94.01% of the company’s stock.

Insider Buying and Selling at Waters

In other news, Director Christopher Kuebler sold 3,626 shares of the business’s stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the sale, the director directly owned 17,808 shares of the company’s stock, valued at $7,086,515.52. The trade was a 16.92% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.31% of the stock is owned by company insiders.

Waters Stock Down 0.3%

NYSE:WAT opened at $455.89 on Friday. The company has a market cap of $44.79 billion, a PE ratio of 113.69, a P/E/G ratio of 2.66 and a beta of 1.15. Waters Corporation has a twelve month low of $282.77 and a twelve month high of $465.36. The company has a current ratio of 1.86, a quick ratio of 1.29 and a debt-to-equity ratio of 0.32. The company’s 50 day moving average is $423.54 and its two-hundred day moving average is $380.89.

Waters (NYSE:WAT – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.01 by $0.04. The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.62 billion. Waters had a net margin of 3.58% and a return on equity of 11.27%. The business’s quarterly revenue was up 113.3% on a year-over-year basis. During the same quarter last year, the company posted $2.95 earnings per share. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. Analysts anticipate that Waters Corporation will post 14.56 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Wells Fargo & Company increased their target price on shares of Waters from $370.00 to $400.00 and gave the company an “equal weight” rating in a research report on Wednesday, August 5th. Barclays upped their price target on Waters from $460.00 to $500.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 7th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $400.00 price target on shares of Waters in a research report on Wednesday, August 5th. Sanford C. Bernstein began coverage on Waters in a research report on Friday, June 26th. They issued an “outperform” rating and a $435.00 price objective for the company. Finally, Guggenheim raised their price objective on Waters from $440.00 to $490.00 and gave the stock a “buy” rating in a research report on Thursday, October 1st. Two research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $443.79.

Read Our Latest Analysis on Waters

About Waters

(Free Report)

Waters Corporation (NYSE:WAT) develops and manufactures analytical technologies used to measure, identify and characterize chemical and biological substances. Its customers include pharmaceutical and biotechnology companies, industrial manufacturers, academic and government laboratories, and organizations involved in food, environmental and clinical testing.

The company’s product portfolio includes high-performance liquid chromatography and ultra-performance liquid chromatography systems, mass spectrometers, chromatography columns and consumables, and laboratory software for data management and analysis.